nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Carmustine—lymphatic system cancer	0.0791	0.471	CbGbCtD
Ropinirole—CYP3A4—Cytarabine—lymphatic system cancer	0.0283	0.168	CbGbCtD
Ropinirole—CYP3A4—Teniposide—lymphatic system cancer	0.0279	0.166	CbGbCtD
Ropinirole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0195	0.116	CbGbCtD
Ropinirole—CYP3A4—Vincristine—lymphatic system cancer	0.0134	0.0798	CbGbCtD
Ropinirole—Vision blurred—Carmustine—lymphatic system cancer	0.000632	0.000759	CcSEcCtD
Ropinirole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00063	0.000757	CcSEcCtD
Ropinirole—Tremor—Carmustine—lymphatic system cancer	0.000628	0.000755	CcSEcCtD
Ropinirole—Oedema—Bleomycin—lymphatic system cancer	0.000627	0.000753	CcSEcCtD
Ropinirole—Infection—Bleomycin—lymphatic system cancer	0.000622	0.000748	CcSEcCtD
Ropinirole—Anaemia—Carmustine—lymphatic system cancer	0.000619	0.000745	CcSEcCtD
Ropinirole—Back pain—Vincristine—lymphatic system cancer	0.000619	0.000744	CcSEcCtD
Ropinirole—Vomiting—Teniposide—lymphatic system cancer	0.000618	0.000743	CcSEcCtD
Ropinirole—Sepsis—Methotrexate—lymphatic system cancer	0.000616	0.000741	CcSEcCtD
Ropinirole—Agitation—Carmustine—lymphatic system cancer	0.000616	0.00074	CcSEcCtD
Ropinirole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000613	0.000737	CcSEcCtD
Ropinirole—Asthenia—Fludarabine—lymphatic system cancer	0.000613	0.000737	CcSEcCtD
Ropinirole—Rash—Teniposide—lymphatic system cancer	0.000613	0.000737	CcSEcCtD
Ropinirole—Dermatitis—Teniposide—lymphatic system cancer	0.000612	0.000736	CcSEcCtD
Ropinirole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00061	0.000733	CcSEcCtD
Ropinirole—Headache—Teniposide—lymphatic system cancer	0.000609	0.000732	CcSEcCtD
Ropinirole—Pruritus—Fludarabine—lymphatic system cancer	0.000605	0.000727	CcSEcCtD
Ropinirole—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000604	0.000726	CcSEcCtD
Ropinirole—Back pain—Mitoxantrone—lymphatic system cancer	0.000603	0.000724	CcSEcCtD
Ropinirole—Leukopenia—Carmustine—lymphatic system cancer	0.0006	0.000721	CcSEcCtD
Ropinirole—Anorexia—Bleomycin—lymphatic system cancer	0.000597	0.000718	CcSEcCtD
Ropinirole—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000595	0.000716	CcSEcCtD
Ropinirole—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000593	0.000712	CcSEcCtD
Ropinirole—Anaemia—Vincristine—lymphatic system cancer	0.000591	0.000711	CcSEcCtD
Ropinirole—Agitation—Vincristine—lymphatic system cancer	0.000588	0.000707	CcSEcCtD
Ropinirole—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000587	0.000706	CcSEcCtD
Ropinirole—Polyuria—Methotrexate—lymphatic system cancer	0.000587	0.000706	CcSEcCtD
Ropinirole—Hypotension—Bleomycin—lymphatic system cancer	0.000585	0.000704	CcSEcCtD
Ropinirole—Diarrhoea—Fludarabine—lymphatic system cancer	0.000585	0.000703	CcSEcCtD
Ropinirole—Convulsion—Carmustine—lymphatic system cancer	0.000581	0.000698	CcSEcCtD
Ropinirole—Hypertension—Carmustine—lymphatic system cancer	0.000579	0.000695	CcSEcCtD
Ropinirole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000578	0.000695	CcSEcCtD
Ropinirole—Nausea—Teniposide—lymphatic system cancer	0.000578	0.000694	CcSEcCtD
Ropinirole—Anaemia—Mitoxantrone—lymphatic system cancer	0.000576	0.000692	CcSEcCtD
Ropinirole—Vertigo—Vincristine—lymphatic system cancer	0.000575	0.000691	CcSEcCtD
Ropinirole—Leukopenia—Vincristine—lymphatic system cancer	0.000573	0.000688	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000571	0.000686	CcSEcCtD
Ropinirole—Chest pain—Carmustine—lymphatic system cancer	0.00057	0.000686	CcSEcCtD
Ropinirole—Myalgia—Carmustine—lymphatic system cancer	0.00057	0.000686	CcSEcCtD
Ropinirole—Anxiety—Carmustine—lymphatic system cancer	0.000569	0.000683	CcSEcCtD
Ropinirole—Paraesthesia—Bleomycin—lymphatic system cancer	0.000563	0.000676	CcSEcCtD
Ropinirole—Malaise—Mitoxantrone—lymphatic system cancer	0.000562	0.000675	CcSEcCtD
Ropinirole—Dyspnoea—Bleomycin—lymphatic system cancer	0.000559	0.000671	CcSEcCtD
Ropinirole—Renal failure acute—Methotrexate—lymphatic system cancer	0.000558	0.000671	CcSEcCtD
Ropinirole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000558	0.00067	CcSEcCtD
Ropinirole—Convulsion—Vincristine—lymphatic system cancer	0.000554	0.000666	CcSEcCtD
Ropinirole—Hypertension—Vincristine—lymphatic system cancer	0.000552	0.000664	CcSEcCtD
Ropinirole—Confusional state—Carmustine—lymphatic system cancer	0.000551	0.000663	CcSEcCtD
Ropinirole—Oedema—Carmustine—lymphatic system cancer	0.000547	0.000657	CcSEcCtD
Ropinirole—Decreased appetite—Bleomycin—lymphatic system cancer	0.000545	0.000655	CcSEcCtD
Ropinirole—Myalgia—Vincristine—lymphatic system cancer	0.000545	0.000655	CcSEcCtD
Ropinirole—Visual disturbance—Methotrexate—lymphatic system cancer	0.000544	0.000654	CcSEcCtD
Ropinirole—Cough—Mitoxantrone—lymphatic system cancer	0.000544	0.000653	CcSEcCtD
Ropinirole—Infection—Carmustine—lymphatic system cancer	0.000543	0.000653	CcSEcCtD
Ropinirole—Vomiting—Fludarabine—lymphatic system cancer	0.000543	0.000653	CcSEcCtD
Ropinirole—Convulsion—Mitoxantrone—lymphatic system cancer	0.00054	0.000649	CcSEcCtD
Ropinirole—Rash—Fludarabine—lymphatic system cancer	0.000539	0.000648	CcSEcCtD
Ropinirole—Dermatitis—Fludarabine—lymphatic system cancer	0.000538	0.000647	CcSEcCtD
Ropinirole—Hypertension—Mitoxantrone—lymphatic system cancer	0.000538	0.000647	CcSEcCtD
Ropinirole—Pain—Bleomycin—lymphatic system cancer	0.000536	0.000644	CcSEcCtD
Ropinirole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000535	0.000644	CcSEcCtD
Ropinirole—Headache—Fludarabine—lymphatic system cancer	0.000535	0.000644	CcSEcCtD
Ropinirole—Tachycardia—Carmustine—lymphatic system cancer	0.000534	0.000642	CcSEcCtD
Ropinirole—Chest pain—Mitoxantrone—lymphatic system cancer	0.00053	0.000638	CcSEcCtD
Ropinirole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00053	0.000638	CcSEcCtD
Ropinirole—Myalgia—Mitoxantrone—lymphatic system cancer	0.00053	0.000638	CcSEcCtD
Ropinirole—Anxiety—Mitoxantrone—lymphatic system cancer	0.000529	0.000635	CcSEcCtD
Ropinirole—Lethargy—Methotrexate—lymphatic system cancer	0.000526	0.000632	CcSEcCtD
Ropinirole—Discomfort—Mitoxantrone—lymphatic system cancer	0.000524	0.00063	CcSEcCtD
Ropinirole—Oedema—Vincristine—lymphatic system cancer	0.000522	0.000628	CcSEcCtD
Ropinirole—Anorexia—Carmustine—lymphatic system cancer	0.000521	0.000627	CcSEcCtD
Ropinirole—Infection—Vincristine—lymphatic system cancer	0.000519	0.000623	CcSEcCtD
Ropinirole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000516	0.000621	CcSEcCtD
Ropinirole—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000515	0.00062	CcSEcCtD
Ropinirole—Confusional state—Mitoxantrone—lymphatic system cancer	0.000513	0.000616	CcSEcCtD
Ropinirole—Nervous system disorder—Vincristine—lymphatic system cancer	0.000512	0.000615	CcSEcCtD
Ropinirole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000511	0.000614	CcSEcCtD
Ropinirole—Hypotension—Carmustine—lymphatic system cancer	0.000511	0.000614	CcSEcCtD
Ropinirole—Oedema—Mitoxantrone—lymphatic system cancer	0.000508	0.000611	CcSEcCtD
Ropinirole—Nausea—Fludarabine—lymphatic system cancer	0.000508	0.00061	CcSEcCtD
Ropinirole—Infection—Mitoxantrone—lymphatic system cancer	0.000505	0.000607	CcSEcCtD
Ropinirole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000505	0.000607	CcSEcCtD
Ropinirole—Shock—Mitoxantrone—lymphatic system cancer	0.0005	0.000601	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000498	0.000599	CcSEcCtD
Ropinirole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000498	0.000598	CcSEcCtD
Ropinirole—Urticaria—Bleomycin—lymphatic system cancer	0.000498	0.000598	CcSEcCtD
Ropinirole—Anorexia—Vincristine—lymphatic system cancer	0.000498	0.000598	CcSEcCtD
Ropinirole—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000496	0.000597	CcSEcCtD
Ropinirole—Body temperature increased—Bleomycin—lymphatic system cancer	0.000495	0.000595	CcSEcCtD
Ropinirole—Insomnia—Carmustine—lymphatic system cancer	0.000495	0.000595	CcSEcCtD
Ropinirole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000494	0.000594	CcSEcCtD
Ropinirole—Irritability—Methotrexate—lymphatic system cancer	0.000492	0.000591	CcSEcCtD
Ropinirole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000491	0.000591	CcSEcCtD
Ropinirole—Paraesthesia—Carmustine—lymphatic system cancer	0.000491	0.00059	CcSEcCtD
Ropinirole—Mood swings—Methotrexate—lymphatic system cancer	0.000488	0.000587	CcSEcCtD
Ropinirole—Hypotension—Vincristine—lymphatic system cancer	0.000488	0.000586	CcSEcCtD
Ropinirole—Dyspnoea—Carmustine—lymphatic system cancer	0.000488	0.000586	CcSEcCtD
Ropinirole—Somnolence—Carmustine—lymphatic system cancer	0.000486	0.000584	CcSEcCtD
Ropinirole—Anorexia—Mitoxantrone—lymphatic system cancer	0.000485	0.000583	CcSEcCtD
Ropinirole—Ataxia—Methotrexate—lymphatic system cancer	0.000485	0.000583	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000476	0.000572	CcSEcCtD
Ropinirole—Decreased appetite—Carmustine—lymphatic system cancer	0.000475	0.000571	CcSEcCtD
Ropinirole—Hypotension—Mitoxantrone—lymphatic system cancer	0.000475	0.000571	CcSEcCtD
Ropinirole—Insomnia—Vincristine—lymphatic system cancer	0.000472	0.000568	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000472	0.000568	CcSEcCtD
Ropinirole—Paraesthesia—Vincristine—lymphatic system cancer	0.000469	0.000564	CcSEcCtD
Ropinirole—Pain—Carmustine—lymphatic system cancer	0.000468	0.000562	CcSEcCtD
Ropinirole—Constipation—Carmustine—lymphatic system cancer	0.000468	0.000562	CcSEcCtD
Ropinirole—Breast disorder—Methotrexate—lymphatic system cancer	0.000466	0.00056	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000463	0.000557	CcSEcCtD
Ropinirole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000462	0.000555	CcSEcCtD
Ropinirole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000457	0.000549	CcSEcCtD
Ropinirole—Decreased appetite—Vincristine—lymphatic system cancer	0.000454	0.000546	CcSEcCtD
Ropinirole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000453	0.000545	CcSEcCtD
Ropinirole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000452	0.000543	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000451	0.000542	CcSEcCtD
Ropinirole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000451	0.000542	CcSEcCtD
Ropinirole—Fatigue—Vincristine—lymphatic system cancer	0.00045	0.000541	CcSEcCtD
Ropinirole—Asthenia—Bleomycin—lymphatic system cancer	0.00045	0.00054	CcSEcCtD
Ropinirole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000448	0.000538	CcSEcCtD
Ropinirole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000447	0.000538	CcSEcCtD
Ropinirole—Pain—Vincristine—lymphatic system cancer	0.000446	0.000537	CcSEcCtD
Ropinirole—Constipation—Vincristine—lymphatic system cancer	0.000446	0.000537	CcSEcCtD
Ropinirole—Asthma—Methotrexate—lymphatic system cancer	0.000445	0.000535	CcSEcCtD
Ropinirole—Pruritus—Bleomycin—lymphatic system cancer	0.000443	0.000533	CcSEcCtD
Ropinirole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000442	0.000531	CcSEcCtD
Ropinirole—Eosinophilia—Methotrexate—lymphatic system cancer	0.000441	0.00053	CcSEcCtD
Ropinirole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000438	0.000527	CcSEcCtD
Ropinirole—Pancreatitis—Methotrexate—lymphatic system cancer	0.000437	0.000525	CcSEcCtD
Ropinirole—Pain—Mitoxantrone—lymphatic system cancer	0.000435	0.000523	CcSEcCtD
Ropinirole—Constipation—Mitoxantrone—lymphatic system cancer	0.000435	0.000523	CcSEcCtD
Ropinirole—Body temperature increased—Carmustine—lymphatic system cancer	0.000432	0.00052	CcSEcCtD
Ropinirole—Abdominal pain—Carmustine—lymphatic system cancer	0.000432	0.00052	CcSEcCtD
Ropinirole—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000427	0.000513	CcSEcCtD
Ropinirole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000427	0.000513	CcSEcCtD
Ropinirole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000419	0.000504	CcSEcCtD
Ropinirole—Dysuria—Methotrexate—lymphatic system cancer	0.000417	0.000501	CcSEcCtD
Ropinirole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000416	0.0005	CcSEcCtD
Ropinirole—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000414	0.000498	CcSEcCtD
Ropinirole—Abdominal pain—Vincristine—lymphatic system cancer	0.000413	0.000496	CcSEcCtD
Ropinirole—Body temperature increased—Vincristine—lymphatic system cancer	0.000413	0.000496	CcSEcCtD
Ropinirole—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00041	0.000493	CcSEcCtD
Ropinirole—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000407	0.000489	CcSEcCtD
Ropinirole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000404	0.000486	CcSEcCtD
Ropinirole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000403	0.000484	CcSEcCtD
Ropinirole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000402	0.000483	CcSEcCtD
Ropinirole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000402	0.000483	CcSEcCtD
Ropinirole—Pneumonia—Methotrexate—lymphatic system cancer	0.000399	0.00048	CcSEcCtD
Ropinirole—Vomiting—Bleomycin—lymphatic system cancer	0.000398	0.000479	CcSEcCtD
Ropinirole—Infestation—Methotrexate—lymphatic system cancer	0.000397	0.000477	CcSEcCtD
Ropinirole—Infestation NOS—Methotrexate—lymphatic system cancer	0.000397	0.000477	CcSEcCtD
Ropinirole—Depression—Methotrexate—lymphatic system cancer	0.000396	0.000476	CcSEcCtD
Ropinirole—Rash—Bleomycin—lymphatic system cancer	0.000395	0.000475	CcSEcCtD
Ropinirole—Dermatitis—Bleomycin—lymphatic system cancer	0.000395	0.000474	CcSEcCtD
Ropinirole—Asthenia—Carmustine—lymphatic system cancer	0.000392	0.000472	CcSEcCtD
Ropinirole—Stomatitis—Methotrexate—lymphatic system cancer	0.000387	0.000465	CcSEcCtD
Ropinirole—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000386	0.000464	CcSEcCtD
Ropinirole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000385	0.000462	CcSEcCtD
Ropinirole—Haematuria—Methotrexate—lymphatic system cancer	0.000379	0.000455	CcSEcCtD
Ropinirole—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000376	0.000452	CcSEcCtD
Ropinirole—Epistaxis—Methotrexate—lymphatic system cancer	0.000375	0.00045	CcSEcCtD
Ropinirole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000375	0.00045	CcSEcCtD
Ropinirole—Asthenia—Vincristine—lymphatic system cancer	0.000375	0.00045	CcSEcCtD
Ropinirole—Diarrhoea—Carmustine—lymphatic system cancer	0.000374	0.00045	CcSEcCtD
Ropinirole—Nausea—Bleomycin—lymphatic system cancer	0.000372	0.000447	CcSEcCtD
Ropinirole—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000371	0.000446	CcSEcCtD
Ropinirole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000365	0.000439	CcSEcCtD
Ropinirole—Dizziness—Carmustine—lymphatic system cancer	0.000362	0.000435	CcSEcCtD
Ropinirole—Haemoglobin—Methotrexate—lymphatic system cancer	0.000358	0.000431	CcSEcCtD
Ropinirole—Diarrhoea—Vincristine—lymphatic system cancer	0.000357	0.000429	CcSEcCtD
Ropinirole—Haemorrhage—Methotrexate—lymphatic system cancer	0.000357	0.000429	CcSEcCtD
Ropinirole—Pharyngitis—Methotrexate—lymphatic system cancer	0.000354	0.000425	CcSEcCtD
Ropinirole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000352	0.000423	CcSEcCtD
Ropinirole—Urethral disorder—Methotrexate—lymphatic system cancer	0.00035	0.00042	CcSEcCtD
Ropinirole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000348	0.000418	CcSEcCtD
Ropinirole—Vomiting—Carmustine—lymphatic system cancer	0.000348	0.000418	CcSEcCtD
Ropinirole—Dizziness—Vincristine—lymphatic system cancer	0.000345	0.000415	CcSEcCtD
Ropinirole—Rash—Carmustine—lymphatic system cancer	0.000345	0.000415	CcSEcCtD
Ropinirole—Dermatitis—Carmustine—lymphatic system cancer	0.000344	0.000414	CcSEcCtD
Ropinirole—Visual impairment—Methotrexate—lymphatic system cancer	0.000344	0.000413	CcSEcCtD
Ropinirole—Headache—Carmustine—lymphatic system cancer	0.000343	0.000412	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—lymphatic system cancer	0.000333	0.000401	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—lymphatic system cancer	0.000332	0.0004	CcSEcCtD
Ropinirole—Vomiting—Vincristine—lymphatic system cancer	0.000332	0.000399	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000331	0.000398	CcSEcCtD
Ropinirole—Rash—Vincristine—lymphatic system cancer	0.000329	0.000396	CcSEcCtD
Ropinirole—Dermatitis—Vincristine—lymphatic system cancer	0.000329	0.000395	CcSEcCtD
Ropinirole—Headache—Vincristine—lymphatic system cancer	0.000327	0.000393	CcSEcCtD
Ropinirole—Nausea—Carmustine—lymphatic system cancer	0.000325	0.000391	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—lymphatic system cancer	0.000323	0.000389	CcSEcCtD
Ropinirole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000323	0.000389	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000322	0.000387	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000321	0.000386	CcSEcCtD
Ropinirole—Rash—Mitoxantrone—lymphatic system cancer	0.000321	0.000385	CcSEcCtD
Ropinirole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00032	0.000385	CcSEcCtD
Ropinirole—Chills—Methotrexate—lymphatic system cancer	0.00032	0.000385	CcSEcCtD
Ropinirole—Headache—Mitoxantrone—lymphatic system cancer	0.000319	0.000383	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—lymphatic system cancer	0.000315	0.000379	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—lymphatic system cancer	0.000312	0.000376	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—lymphatic system cancer	0.00031	0.000373	CcSEcCtD
Ropinirole—Nausea—Vincristine—lymphatic system cancer	0.00031	0.000373	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000304	0.000365	CcSEcCtD
Ropinirole—Nausea—Mitoxantrone—lymphatic system cancer	0.000302	0.000363	CcSEcCtD
Ropinirole—Back pain—Methotrexate—lymphatic system cancer	0.0003	0.000361	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—lymphatic system cancer	0.000293	0.000352	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000288	0.000346	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—lymphatic system cancer	0.000287	0.000345	CcSEcCtD
Ropinirole—Malaise—Methotrexate—lymphatic system cancer	0.00028	0.000336	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—lymphatic system cancer	0.000279	0.000335	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—lymphatic system cancer	0.000278	0.000334	CcSEcCtD
Ropinirole—Cough—Methotrexate—lymphatic system cancer	0.000271	0.000326	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—lymphatic system cancer	0.000269	0.000323	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—lymphatic system cancer	0.000264	0.000318	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—lymphatic system cancer	0.000264	0.000318	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—lymphatic system cancer	0.000264	0.000318	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000262	0.000315	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—lymphatic system cancer	0.000261	0.000314	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—lymphatic system cancer	0.000255	0.000307	CcSEcCtD
Ropinirole—Infection—Methotrexate—lymphatic system cancer	0.000252	0.000303	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000248	0.000299	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000248	0.000298	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—lymphatic system cancer	0.000246	0.000296	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000245	0.000294	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—lymphatic system cancer	0.000241	0.00029	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—lymphatic system cancer	0.000237	0.000285	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000231	0.000277	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—lymphatic system cancer	0.000229	0.000275	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—lymphatic system cancer	0.000227	0.000273	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—lymphatic system cancer	0.000226	0.000271	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—lymphatic system cancer	0.000225	0.000271	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000223	0.000268	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—lymphatic system cancer	0.00022	0.000265	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000219	0.000263	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—lymphatic system cancer	0.000218	0.000263	CcSEcCtD
Ropinirole—Pain—Methotrexate—lymphatic system cancer	0.000217	0.00026	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000209	0.000251	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000207	0.000249	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—lymphatic system cancer	0.000201	0.000242	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—lymphatic system cancer	0.0002	0.000241	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—lymphatic system cancer	0.0002	0.000241	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000187	0.000224	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—lymphatic system cancer	0.000182	0.000218	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—lymphatic system cancer	0.000179	0.000215	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000173	0.000208	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—lymphatic system cancer	0.000168	0.000201	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—lymphatic system cancer	0.000161	0.000194	CcSEcCtD
Ropinirole—Rash—Methotrexate—lymphatic system cancer	0.00016	0.000192	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—lymphatic system cancer	0.00016	0.000192	CcSEcCtD
Ropinirole—Headache—Methotrexate—lymphatic system cancer	0.000159	0.000191	CcSEcCtD
Ropinirole—Nausea—Methotrexate—lymphatic system cancer	0.00015	0.000181	CcSEcCtD
